RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to $142.00. The firm maintained a Sector Perform rating on the stock. The upgrade comes as Morgan Stanley's stock trades near its 52-week high of $136.

In a report released yesterday, Kenneth Herbert from RBC Capital maintained a Hold rating on L3Harris Technologies (LHX – Research Report),

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Cigna (CI – Research Report), with a price target of

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his tenure.

Bank stocks have been on a post-election upswing, with the KBW Nasdaq Bank Index ( ^BKX) up 14% since Trump won the presidency. Morgan Stanley has notched a 17% gain. Investors have a dinner plate to choose from to explain the bullishness.

I don't think there's going to be some kind of unfettered unleashing of anticompetitive dynamics of company A and company B suddenly owning a market space," Morgan Stanley chairman and CEO Ted ...

RBC Capital analyst Sabahat Khan reiterated a Hold rating on Waste Management (WM – Research Report) today and set a price target of $227.00.

Exelixis Inc (EXEL) stock saw a modest uptick, ending the day at $32.73 which represents a slight increase of $0.35 or 1.08% from the prior close of $32.38. The stock opened at $32.92 and touched a low of $32.

Wall Street analysts largely maintained bullish views on IBM (NYSE:IBM) after the tech giant's fourth-quarter results and outlook surpassed expectations. Shares of IBM jumped about 9% premarket on Thursday.

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, National Bank economist Warren Lovely noted the important fact that global interest in Canadian bonds remains high,

Dyne Therapeutics Inc (DYN) stock saw a decline, ending the day at $13.67 which represents a decrease of $-0.05 or -0.36% from the prior close of $13.72. The stock opened at $13.74 and touched a low of $13.

Microsoft Corporation MSFT analysts balance the positives and negatives of Azure’s weakness and strength in AI from the company’s quarterly financial results. Morgan Stanley analyst Keith Weiss maintained an Overweight rating on Microsoft and lowered the price target from $540 to $530.